Second-Line Axi-Cel Prolongs Survival Over SOC in Elderly Patients With R/R LBCL
Venetoclax Is Associated With Durable ORRs in Real-World Population of BTK Inhibitor–Exposed CLL/SLL
Ultrasensitive BCMA CARs Deliver Responses With Tolerable Safety in R/R Multiple Myeloma
Golidocitinib Demonstrates Efficacy in Relapsed/Refractory PTCL
